Owing to the impact of conventional cytotoxic therapies on tumor-targeting immune responses, we sought to quantitatively evaluate the dynamic characters of RT-induced alterations in PD-1/PD-L1 expression level and immune cell composition. The gene discussed is CD274; the disease is neoplasm.